OverviewSuggest Edit

Baxter International develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The Company operates through three segments: BioScience, Medication Delivery, and Renal. It offers peritoneal dialysis and hemodialysis, renal replacement therapies and other organ support therapies, sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, drug reconstitution devices, and parenteral nutrition therapies. ... Show more
TypePublic
Founded1931
HQDeerfield, US
Websitebaxter.com
Employee Ratings3.2

Latest Updates

Employees (est.) (Nov 2018)47,000
Job Openings644
Revenue (FY, 2017)$10.6 B(+4%)
Share Price (Feb 2019)$73.4 (+2%)

Key People/Management at Baxter International

Jose Almeida

Jose Almeida

Chairman, President and Chief Executive Officer
John Forsyth

John Forsyth

Chairman and Chief Executive Officer, Wellmark Blue Cross and Blue Shield
James Gavin

James Gavin

Chief Executive Officer and Chief Medical Officer, Healing Our Village, Inc
Munib Islam

Munib Islam

Partner and Head of Equities Research, Third Point LLC
Michael Mahoney

Michael Mahoney

Chairman, President and Chief Executive Officer, Boston Scientific Corporation
Cathy Smith

Cathy Smith

Executive Vice President and Chief Financial Officer, Target Corporation
Show more

Baxter International Office Locations

Baxter International has offices in Deerfield, Tulsa, Swedesboro, Ontario and in 34 other locations
Deerfield, US (HQ)
One Baxter Parkway
Show all (38)
Report incorrect company information

Baxter International Financials and Metrics

Baxter International Revenue

Embed Graph
View revenue for all periods
Baxter International's revenue was reported to be $10.56 b in FY, 2017
USD

Revenue (Q2, 2018)

2.8b

Gross profit (Q2, 2018)

1.2b

Gross profit margin (Q2, 2018), %

43.6%

Net income (Q2, 2018)

343.0m

EBIT (Q2, 2018)

384.0m

Market capitalization (15-Feb-2019)

39.1b

Closing stock price (15-Feb-2019)

73.4

Cash (30-Jun-2018)

2.9b
Baxter International's current market capitalization is $39.1 b.
Annual
USDFY, 2015FY, 2016FY, 2017

Revenue

10.0b10.2b10.6b

Revenue growth, %

(40%)2%

Cost of goods sold

5.8b6.1b6.1b

Gross profit

4.1b4.1b4.5b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Revenue

3.8b4.0b4.3b4.2b3.8b3.9b2.5b2.4b2.6b2.6b2.5b2.6b2.7b2.8b

Cost of goods sold

1.8b2.0b2.2b2.1b2.0b2.0b1.5b1.4b1.6b1.5b1.4b1.5b1.6b1.6b

Gross profit

1.9b2.0b2.0b2.1b1.8b1.9b1.0b965.0m972.0m1.1b1.0b1.1b1.1b1.2b

Gross profit Margin, %

52%50%48%49%48%49%42%41%38%42%42%43%42%44%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

2.7b2.9b2.2b2.8b3.4b

Inventories

3.5b3.6b1.6b1.4b1.5b

Current Assets

10.0b10.4b11.8b6.6b7.3b

PP&E

7.8b8.7b4.4b4.3b4.6b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Cash

2.4b2.0b1.9b2.1b2.5b6.7b2.0b2.2b2.6b2.6b2.9b3.8b2.9b2.9b

Inventories

3.6b3.7b3.8b3.7b3.5b3.8b1.7b1.7b1.6b1.6b1.5b1.5b1.6b1.6b

Current Assets

9.6b9.4b9.5b9.6b9.7b14.5b11.1b8.0b6.8b6.6b6.6b7.7b7.0b6.9b

PP&E

7.5b8.0b8.2b8.4b8.5b9.0b4.3b4.4b4.3b4.3b4.3b4.3b4.6b4.5b
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

2.0b2.5b968.0m5.0b717.0m

Depreciation and Amortization

761.0m

Inventories

(311.0m)(439.0m)1.6b80.0m76.0m

Accounts Payable

84.0m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Net Income

544.0m556.0m1.1b468.0m430.0m762.0m763.0m3.4b4.6b4.7b272.0m537.0m389.0m732.0m

Depreciation and Amortization

236.0m489.0m497.0m593.0m189.0m395.0m599.0m194.0m378.0m192.0m387.0m

Inventories

(233.0m)(360.0m)(439.0m)(205.0m)(26.0m)(25.0m)(11.0m)(29.0m)(38.0m)(56.0m)(134.0m)

Accounts Payable

(236.0m)(222.0m)(34.0m)14.0m(343.0m)(326.0m)(262.0m)(112.0m)(103.0m)(109.0m)
USDY, 2018

Financial Leverage

1.9 x
Show all financial metrics
Report incorrect company information

Baxter International Online and Social Media Presence

Embed Graph
Report incorrect company information

Baxter International News and Updates

Discover how Global Clinical Microbiology Market is growing with technological advancements, Market strategies of the key players such as Courtney Thorne, Fresenius SE & Co. KGaA, Baxter International Inc.

Global Clinical Microbiology Market 2025 presents a comprehensive qualitative and quantitative data relating to the predictable impact of major growth drivers, limitations, and inclinations influencing the global market. Posted via Industry Today. Follow us on Twitter @IndustryToday

New Study Inspects Kidney Dialysis Centers Market 2019 | B. Braun Melsungen Ag, Baxter International Inc., Fresenius Medical Care Ag & Co. Kgaa, Davita Inc., Nipro Corporation

Kidney dialysis. The main purpose of dialysis is to help impaired renal function. When your kidneys are damaged, they are no longer able to remove wastes and excess fluid from your bloodstream efficiently. Posted via Industry Today. Follow us on Twitter @IndustryToday

Artificial Blood Market 2019: Focusing on Key Vendors like Dextro-Sang Corporation, BioPure Corporation, Sangart, Inc., Northfield Laboratories, Baxter International, Dentritech, Inc.

A blood substitute is also called as artificial blood is a substance used to mimic and fulfill some functions of biological blood. It aims to provide an alternative to blood transfusion, which is transferring blood or blood-based products from one person into another. Posted via Industry Today. Foll…

Cancer Supportive Care Drugs Market 2026 Growth Analysis By Global Key Players such as Johnson & Johnson, Novartis AG, F.Hoffmann La-Roche Ltd., Amgen, Inc., Baxter International, Inc., Teva Pharmaceutical Industries Ltd.

High prevalence of various types of cancer is a key factor supporting growth of the global cancer supportive care drugs market. Cancer is one of the most prevalent fatal chronic disorders with a high mortality rate due to its invasive nature and prolonged duration of disease. Posted via Industry Tod…

Scopolamine Market is Anticipated To Register A Significant CAGR Over A Forecast Period 2018-2026 By Top Players Baxter International Inc., GlaxoSmithKline plc. Novartis AG, Perrigo Company plc., Caleb Pharmaceuticals, Inc.

Scopolamine is an alkaloid drug extracted from plant called henbane to treat nausea and motion sickness and further to dilate the pupil in ophthalmic procedures. Posted via Industry Today. Follow us on Twitter @IndustryToday

Advanced Drug Delivery Systems Market Excellent Growth by 2023| Comprehensive Study on Key Players: Pfizer, Abbott Laboratories, Baxter International

If you are involved in the Global Advanced Drug Delivery Systems industry or intend to be, then this study will provide you comprehensive outlook. It’s vital you keep your market knowledge up to date segmented by major players. If you have a different set of players/manufacturers according to geogra…
Show more
Report incorrect company information

Baxter International Company Life and Culture

Report incorrect company information

Baxter International Frequently Asked Questions

  • When was Baxter International founded?

    Baxter International was founded in 1931.

  • Who are Baxter International key executives?

    Baxter International's key executives are Jose Almeida, John Forsyth and James Gavin.

  • How many employees does Baxter International have?

    Baxter International has 47,000 employees.

  • What is Baxter International revenue?

    Latest Baxter International annual revenue is $10.6 b.

  • What is Baxter International revenue per employee?

    Latest Baxter International revenue per employee is $224.7 k.

  • Who are Baxter International competitors?

    Competitors of Baxter International include Fresenius Medical Care, Medtronic and Opiant Pharmaceuticals.

  • Where is Baxter International headquarters?

    Baxter International headquarters is located at One Baxter Parkway, Deerfield.

  • Where are Baxter International offices?

    Baxter International has offices in Deerfield, Tulsa, Swedesboro, Ontario and in 34 other locations.

  • How many offices does Baxter International have?

    Baxter International has 38 offices.